Developmental DisabilitiesNCT07869251
90SecondParent Wellbeing: Weekly Health Letters for Parents of Children With Developmental Disabilities
A study testing 90SecondParent Wellbeing in people with Developmental Disabilities and Psychological Wellbeing, run by IWK Health Centre at 1 site in Canada.
Trial summary
Parents of children with developmental disabilities (DD) consistently report significant psychological distress, a vulnerability amplified during the COVID-19 pandemic due to intensified caregiving demands and reduced access to formal supports. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Developmental Disabilities, Psychological Wellbeing, Parental Wellbeing
- What is being tested?
- 90SecondParent Wellbeing
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 500 participants
- Where
- 1 siteCanada
- Study dates
- 19 Oct 2022to 7 Oct 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Parent or caregiver of a child with a developmental disability.
- At least 18 years of age
- Spent a minimum of 20 hours per week, for at least the past 3 months, to care for their child with developmental disabilities
- Living in Canada
- Able to read, write, and understand English.
- Provided informed consent.
- Access to a tablet, smart phone, computer, or internet
Who cannot join
- Not a parent or caregiver of a child with a developmental disability.
- Spent less than 20 hours per week for less than 3 months caring for a child with developmental disabilities
- Didn't live in Canada
- Not able to read, write, and understand English.
- No access to a tablet, smart phone, computer, or internet.
- Did not consent to the study
Trial locations and contacts
1 site in 1 country.
About this study
Parents of children with developmental disabilities (DD) consistently report significant psychological distress, a vulnerability amplified during the COVID-19 pandemic due to intensified caregiving demands and reduced access to formal supports. Scalable e-health interventions offer a promising alternative, yet programs specifically targeting the mental wellbeing of this parent population remain limited. This study aimed to examine the impact of the 90SecondParent Wellbeing e-health intervention on psychological wellbeing, parental wellbeing, and symptoms of depression and anxiety among parents of children with developmental disabilities. A two-arm randomized controlled trial of primary caregivers of children with developmental disabilities was conducted with a wait-list control group. The intervention consisted of 36 weekly health letters (the 90SecondParent Wellbeing program) that addressed child behaviour management, support strategies, and positive psychology principles. Outcomes, including psychological wellbeing (PWBS), parental wellbeing (PWS), depression (PHQ-9), and anxiety (GAD-7), were assessed across three time points ( baseline, immediately after intervention, and 1 month post-intervention (follow-up)).
- Being tested
- 90SecondParent Wellbeing
- Keywords
- Public health e-intervention, Parenting intervention
- Medical subject headings
- Developmental Disabilities
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
90SecondParent WellbeingBehavioural
The intervention consisted of 36 weekly health letters that addressed child behaviour management, support strategies, and positive psychology principles.
| Study group | Role | What they receive |
|---|---|---|
| 90SecondParent Wellbeing Intervention | Experimental | They received 36 weekly health letters (the 90SecondParent Wellbeing program) that addressed child behaviour management, support strategies, and positive psychology principles. Receives: Behavioral: 90SecondParent Wellbeing |
| Waitlist Control Group | No intervention | They didn't receive an intervention and only received access to the health letters after completing the follow-up assessment. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Psychological wellbeing (PWBS)
The Psychological Wellbeing (PWBS) measure assesses six aspects of wellbeing: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance. Items are rated on a 7-point Likert-type scale ranging from 1 (Strongly agree) to 7 (Strongly disagree). Higher scores indicate greater wellbeing. The PWBS was measured at baseline, post-assessment, and follow-up.Total scores range from 18 to 126, with higher scores indicating greater psychological wellbeing.
Measured: Baseline, Immediately after intervention (18 weeks), 1 month post-intervention
Secondary outcomes (1)
Parent Wellbeing
Parent wellbeing was measured using the Parent Well-being Scale. This scale was completed at baseline, immediately after intervention, and at 1-month post-intervention. The Parent Well-being Scale is an 8-item measure that assesses parents' feelings when caring for their child with developmental disabilities. Items are expressed as polar opposites in two columns, separated by ten boxes from 1 to 10. For example, a score of 1 for the stress item means the parent feels very stressed, and a score of 10 means the parent is very relaxed and not stressed at all. Total scores range from 8 to 80, with higher scores indicating greater parent wellbeing and satisfaction
Measured: Baseline, Immediately after intervention (18 weeks), 1 month post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Oct 2026
- Study start19 Oct 2022
- Primary completion7 Oct 2024
- Study completion7 Oct 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Developmental DisabilitiesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 500 participants (actual)
Sponsor and investigators
- Lead sponsor
- IWK Health Centre
- Sponsor type
- University, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR)
- Responsible party
- Principal investigator, Patrick J. McGrath, IWK Health Centre
- Investigators
- Patrick J McGrath, PhD, Principal investigator, IWK Health Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07869251
- Sponsor's protocol ID
- 1027743
- Other IDs
- #CIHR-McGrath-27183.
- Status last verified
- Oct 2026
- First submitted
- 28 Sep 2026
- Last updated
- 9 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Participants were asked to indicate during Informed Consent whether their de-identified data may be shared with other researchers, provided the study is approved by an ethics board and researchers agree to use the data only for the purposes described in the approved research study. De-identified data from all outcome measures will be made available to approved researchers upon request, provided individual participants have provided consent.
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- 90SecondParent Wellbeing: Weekly Health Letters for Parents of Children With Developmental Disabilities
- ClinicalTrials.gov ID
- NCT07869251
- Acronym / sponsor ID
- 1027743
- Keywords
- Public health e-intervention, Parenting intervention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 500 participants (actual)
- Lead sponsor
- IWK Health CentreUniversity, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR)
- Study start
- 19 Oct 2022 (actual)
- Primary completion
- 7 Oct 2024 (actual)
- Study completion
- 7 Oct 2024 (actual)
- First posted
- 9 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Parents of children with developmental disabilities (DD) consistently report significant psychological distress, a vulnerability amplified during the COVID-19 pandemic due to intensified caregiving demands and reduced access to formal supports. Scalable e-health interventions offer a promising alternative, yet programs specifically targeting the mental wellbeing of this parent population remain limited. This study aimed to examine the impact of the 90SecondParent Wellbeing e-health intervention on psychological wellbeing, parental wellbeing, and symptoms of depression and anxiety among parents of children with developmental disabilities. A two-arm randomized controlled trial of primary caregivers of children with developmental disabilities was conducted with a wait-list control group. The intervention consisted of 36 weekly health letters (the 90SecondParent Wellbeing program) that addressed child behaviour management, support strategies, and positive psychology principles. Outcomes, including psychological wellbeing (PWBS), parental wellbeing (PWS), depression (PHQ-9), and anxiety (GAD-7), were assessed across three time points ( baseline, immediately after intervention, and 1 month post-intervention (follow-up)).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 90SecondParent Wellbeing Intervention | Experimental | Behavioral: 90SecondParent WellbeingThey received 36 weekly health letters (the 90SecondParent Wellbeing program) that addressed child behaviour management, support strategies, and positive psychology principles. |
| Waitlist Control Group | No intervention | –They didn't receive an intervention and only received access to the health letters after completing the follow-up assessment. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Parent or caregiver of a child with a developmental disability.
- At least 18 years of age
- Spent a minimum of 20 hours per week, for at least the past 3 months, to care for their child with developmental disabilities
- Living in Canada
- Able to read, write, and understand English.
Key exclusion criteria (6 listed)
- Not a parent or caregiver of a child with a developmental disability.
- Spent less than 20 hours per week for less than 3 months caring for a child with developmental disabilities
- Didn't live in Canada
- Not able to read, write, and understand English.
- No access to a tablet, smart phone, computer, or internet.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 90SecondParent WellbeingThe intervention consisted of 36 weekly health letters that addressed child behaviour management, support strategies, and positive psychology principles. | Behavioural | 90SecondParent Wellbeing Intervention |
Primary outcome
Psychological wellbeing (PWBS)
Time frame: Baseline, Immediately after intervention (18 weeks), 1 month post-intervention
The Psychological Wellbeing (PWBS) measure assesses six aspects of wellbeing: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance. Items are rated on a 7-point Likert-type scale ranging from 1 (Strongly agree) to 7 (Strongly disagree). Higher scores indicate greater wellbeing. The PWBS was measured at baseline, post-assessment, and follow-up.Total scores range from 18 to 126, with higher scores indicating greater psychological wellbeing.
1 secondary outcome
Parent Wellbeing
Time frame: Baseline, Immediately after intervention (18 weeks), 1 month post-intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Individual participant dataSharing planned: Yes. Participants were asked to indicate during Informed Consent whether their de-identified data may be shared with other researchers, provided the study is approved by an ethics board and researchers agree to use the data only for the purposes described in the approved research study. De-identified data from all outcome measures will be made available to approved researchers upon request, provided individual participants have provided consent.
Related trials for Developmental Disabilities
RecruitingPhase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruiting
Sensory-integration Therapy Verses Augumented Reality-based Training in ASD
Autism Spectrum Disorder
Recruiting
Cumulative and Booster Effects of Multisession Prefrontal tDCS in ASD Adolescents
Transcranial Direct Current Stimulation, Autistic Spectrum Disorder
Not yet recruiting
"Family Resilience And Mind-body Enhancement" (FRAME): A Randomised Controlled Trial
Autism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Patrick J McGrath, PhD principal investigator
IWK Health Centre
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 90SecondParent Wellbeing in people with Developmental Disabilities and Psychological Wellbeing, run by IWK Health Centre at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Psychological wellbeing (PWBS) (time frame: Baseline, Immediately after intervention (18 weeks), 1 month post-intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.